Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Joost Schalkwijk
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Anatomy
Disorders
Procedures
Living Beings
Physiology
Phenomena
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
37
van de Kerkhof, P C M
33
Zeeuwen, Patrick
28
van Vlijmen-Willems, Ivonne
27
de Jongh, Gys
21
Bergers, Mieke
19
van Erp, P E J
16
van Ruissen, Fred
10
Zweers, Manon
9
Van De Putte, L B A
9
van den Berg, Wim
9
van der Valk, P G M
9
Pfundt, Rolph
8
Hiemstra, Pieter
8
Kuijpers, AL
8
van Kuppevelt, Toin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Joost Schalkwijk (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lammers G; Tjabringa G S; Schalkwijk J; Daamen W F; van Kuppevelt T H
A molecularly defined array based on native fibrillar collagen for the assessment of skin tissue engineering biomaterials.
Biomaterials 2009;30(31):6213-20.
-
2009: Jansen Patrick A M; Kamsteeg Marijke; Rodijk-Olthuis Diana; van Vlijmen-Willems Ivonne M J J; de Jongh Gys J; Bergers Mieke; Tjabringa Geuranne S; Zeeuwen Patrick L J M; Schalkwijk Joost
Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines.
The Journal of investigative dermatology 2009;129(9):2167-74.
-
2009: Cheng T; Tjabringa G S; van Vlijmen-Willems I M J J; Hitomi K; van Erp P E J; Schalkwijk J; Zeeuwen P L J M
The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis.
The British journal of dermatology 2009;161(2):253-64.
-
2009: Verhoeven E W M; Kraaimaat F W; de Jong E M G J; Schalkwijk J; van de Kerkhof P C M; Evers A W M
Individual differences in the effect of daily stressors on psoriasis: a prospective study.
The British journal of dermatology 2009;161(2):295-9.
-
2009: Voermans Nicol C; van Alfen Nens; Pillen Sigrid; Lammens Martin; Schalkwijk Joost; Zwarts Machiel J; van Rooij Iris A; Hamel Ben C J; van Engelen Baiel G
Neuromuscular involvement in various types of Ehlers-Danlos syndrome.
Annals of neurology 2009;65(6):687-97.
-
2009: Zeeuwen Patrick L J M; Cheng Tsing; Schalkwijk Joost
The biology of cystatin M/E and its cognate target proteases.
The Journal of investigative dermatology 2009;129(6):1327-38.
-
2009: Cheng Tsing; van Vlijmen-Willems Ivonne M J J; Hitomi Kiyotaka; Pasch Marcel C; van Erp Piet E J; Schalkwijk Joost; Zeeuwen Patrick L J M
Colocalization of cystatin M/E and its target proteases suggests a role in terminal differentiation of human hair follicle and nail.
The Journal of investigative dermatology 2009;129(5):1232-42.
-
2009: van Rossum M M; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof P C M; Kiemeney L A L M; Hoogerbrugge N
Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
Archives of dermatological research 2009;301(4):295-9.
-
2009: Jansen Patrick A M; Rodijk-Olthuis Diana; Hollox Edward J; Kamsteeg Marijke; Tjabringa Geuranne S; de Jongh Gys J; van Vlijmen-Willems Ivonne M J J; Bergboer Judith G M; van Rossum Michelle M; de Jong Elke M G J; den Heijer Martin; Evers Andrea W M; Bergers Mieke; Armour John A L; Zeeuwen Patrick L J M; Schalkwijk Joost
Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.
PloS one 2009;4(3):e4725.
-
2008: Voermans N C; Bönnemann C G; Huijing P A; Hamel B C; van Kuppevelt T H; de Haan A; Schalkwijk J; van Engelen B G; Jenniskens G J
Clinical and molecular overlap between myopathies and inherited connective tissue diseases.
Neuromuscular disorders : NMD 2008;18(11):843-56.
-
2008: Tjabringa Geuranne; Bergers Mieke; van Rens Desiree; de Boer Roelie; Lamme Evert; Schalkwijk Joost
Development and validation of human psoriatic skin equivalents.
The American journal of pathology 2008;173(3):815-23.
-
2008: Rinne Tuula; Clements Suzanne E; Lamme Evert; Duijf Pascal H G; Bolat Emine; Meijer Rowdy; Scheffer Hans; Rosser Elisabeth; Tan Tiong Yang; McGrath John A; Schalkwijk Joost; Brunner Han G; Zhou Huiqing; van Bokhoven Hans
A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes.
Human molecular genetics 2008;17(13):1968-77.
-
2008: Egging David F; van Vlijmen-Willems Ivonne; Choi Jiwon; Peeters Anita C T M; van Rens Desiree; Veit Guido; Koch Manuel; Davis Elaine C; Schalkwijk Joost
Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice.
Cell and tissue research 2008;332(3):523-32.
-
2008: van Kilsdonk Jeroen W J; Wilting Roel H; Bergers Mieke; van Muijen Goos N P; Schalkwijk Joost; van Kempen Léon C L T; Swart Guido W M
Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
Cancer research 2008;68(10):3671-9.
-
2008: Simon Anna; Kullberg Bart Jan; Tripet Brian; Boerman Otto C; Zeeuwen Patrick; van der Ven-Jongekrijg Johanna; Verweij Paul; Schalkwijk Joost; Hodges Robert; van der Meer Jos W M; Netea Mihai G
Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.
Antimicrobial agents and chemotherapy 2008;52(4):1407-12.
-
2008: Hollox Edward J; Huffmeier Ulrike; Zeeuwen Patrick L J M; Palla Raquel; Lascorz Jesús; Rodijk-Olthuis Diana; van de Kerkhof Peter C M; Traupe Heiko; de Jongh Gys; den Heijer Martin; Reis André; Armour John A L; Schalkwijk Joost
Psoriasis is associated with increased beta-defensin genomic copy number.
Nature genetics 2008;40(1):23-5.
-
2008: Zeeuwen Patrick L J M; de Jongh Gys J; Rodijk-Olthuis Diana; Kamsteeg Marijke; Verhoosel Renate M; van Rossum Michelle M; Hiemstra Pieter S; Schalkwijk Joost
Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients.
PloS one 2008;3(6):e2301.
-
2007: Voermans N C; Jenniskens G J; Hamel B C; Schalkwijk J; Guicheney P; van Engelen B G
Ehlers-Danlos syndrome due to tenascin-X deficiency: muscle weakness and contractures support overlap with collagen VI myopathies.
American journal of medical genetics. Part A 2007;143A(18):2215-9.
-
2007: Kamsteeg Marijke; Zeeuwen Patrick L J M; de Jongh Gys J; Rodijk-Olthuis Diana; Zeeuwen-Franssen Manon E J; van Erp Piet E J; Schalkwijk Joost
Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic dermatitis: regulation by Th2 cytokines.
The Journal of investigative dermatology 2007;127(7):1786-9.
-
2007: Schalkwijk Joost
Cross-linking of elafin/SKALP to elastic fibers in photodamaged skin: too much of a good thing?
The Journal of investigative dermatology 2007;127(6):1286-7.
-
2007: Egging D F; Peeters A C T M; Grebenchtchikov N; Geurts-Moespot A; Sweep C G J; den Heijer M; Schalkwijk J
Identification and characterization of multiple species of tenascin-X in human serum.
The FEBS journal 2007;274(5):1280-9.
-
2007: Nillesen Suzan T M; Geutjes Paul J; Wismans Ronnie; Schalkwijk Joost; Daamen Willeke F; van Kuppevelt Toin H
Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Biomaterials 2007;28(6):1123-31.
-
2007: Egging David; van den Berkmortel Franka; Taylor Glen; Bristow Jim; Schalkwijk Joost
Interactions of human tenascin-X domains with dermal extracellular matrix molecules.
Archives of dermatological research 2007;298(8):389-96.
-
2007: Zeeuwen Patrick L J M; Ishida-Yamamoto Akemi; van Vlijmen-Willems Ivonne M J J; Cheng Tsing; Bergers Mieke; Iizuka Hajime; Schalkwijk Joost
Colocalization of cystatin M/E and cathepsin V in lamellar granules and corneodesmosomes suggests a functional role in epidermal differentiation.
The Journal of investigative dermatology 2007;127(1):120-8.
-
2007: Egging David; van Vlijmen-Willems Ivonne; van Tongeren Tomas; Schalkwijk Joost; Peeters Anita
Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.
Connective tissue research 2007;48(2):93-8.
-
2007: Armour John A L; Palla Raquel; Zeeuwen Patrick L J M; den Heijer Martin; Schalkwijk Joost; Hollox Edward J
Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats.
Nucleic acids research 2007;35(3):e19.
-
2006: Nillesen S T M; Geutjes P J; Wismans R; Schalkwijk J; Daamen W F; van Kuppevelt T H
Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF.
Journal of controlled release : official journal of the Controlled Release Society 2006;116(2):e88-90.
-
2006: Amigó María; Schalkwijk Joost; Olthuis Diana; De Rosa Salvatore; Payá Miguel; Terencio María Carmen; Lamme Evert
Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation.
Life sciences 2006;79(25):2395-404.
-
2006: Cheng Tsing; Hitomi Kiyotaka; van Vlijmen-Willems Ivonne M J J; de Jongh Gys J; Yamamoto Kanae; Nishi Koji; Watts Colin; Reinheckel Thomas; Schalkwijk Joost; Zeeuwen Patrick L J M
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
The Journal of biological chemistry 2006;281(23):15893-9.
-
2006: Voermans N C; Drost G; van Kampen A; Gabreëls-Festen A A; Lammens M; Hamel B C; Schalkwijk J; van Engelen B G
Recurrent neuropathy associated with Ehlers-Danlos syndrome.
Journal of neurology 2006;253(5):670-1.
-
2006: Zweers Manon C; Peeters Anita C T M; Graafsma Sietze; Kranendonk Steef; van der Vliet J Adam; den Heijer Martin; Schalkwijk Joost
Abdominal aortic aneurysm is associated with high serum levels of tenascin-X and decreased aneurysmal tissue tenascin-X.
Circulation 2006;113(13):1702-7.
-
2006: Egging D F; van Vlijmen I; Starcher B; Gijsen Y; Zweers M C; Blankevoort L; Bristow J; Schalkwijk J
Dermal connective tissue development in mice: an essential role for tenascin-X.
Cell and tissue research 2006;323(3):465-74.
-
2006: Vos Joost B; Datson Nicole A; van Kampen Antoine H; Luyf Angela C; Verhoosel Renate M; Zeeuwen Patrick L; Olthuis Diana; Rabe Klaus F; Schalkwijk Joost; Hiemstra Pieter S
A molecular signature of epithelial host defense: comparative gene expression analysis of cultured bronchial epithelial cells and keratinocytes.
BMC genomics 2006;7():9.
-
2005: de Jongh Gys J; Zeeuwen Patrick L J M; Kucharekova Martina; Pfundt Rolph; van der Valk Pieter G; Blokx Willeke; Dogan Aynur; Hiemstra Pieter S; van de Kerkhof Peter C; Schalkwijk Joost
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis.
The Journal of investigative dermatology 2005;125(6):1163-73.
-
2005: Bristow James; Carey William; Egging David; Schalkwijk Joost
Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome.
American journal of medical genetics. Part C, Seminars in medical genetics 2005;139C(1):24-30.
-
2005: Tjabringa G Sandra; Vos Joost B; Olthuis Diana; Ninaber Dennis K; Rabe Klaus F; Schalkwijk Joost; Hiemstra Pieter S; Zeeuwen Patrick L J M
Host defense effector molecules in mucosal secretions.
FEMS immunology and medical microbiology 2005;45(2):151-8.
-
2005: Vos Joost B; van Sterkenburg Marianne A; Rabe Klaus F; Schalkwijk Joost; Hiemstra Pieter S; Datson Nicole A
Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense.
Physiological genomics 2005;21(3):324-36.
-
2005: Zweers M C; Dean W B; van Kuppevelt T H; Bristow J; Schalkwijk J
Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
Clinical genetics 2005;67(4):330-4.
-
2005: Zweers M C; Kucharekova M; Schalkwijk J
Tenascin-X: a candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome?
Annals of the rheumatic diseases 2005;64(3):504-5.
-
2005: Franssen Manon E J; Zeeuwen Patrick L J M; Vierwinden Gerty; van de Kerkhof Peter C M; Schalkwijk Joost; van Erp Piet E J
Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis.
The Journal of investigative dermatology 2005;124(2):373-83.
-
2005: Zweers Manon C; Schalkwijk Joost; van Kuppevelt Toin H; van Vlijmen-Willems Ivonne M; Bergers Mieke; Lethias Claire; Lamme Evert N
Transplantation of reconstructed human skin on nude mice: a model system to study expression of human tenascin-X and elastic fiber components.
Cell and tissue research 2005;319(2):279-87.
-
2005: Jansen Bastiaan J H; de Jongh Gys; Schalkwijk Joost; van Ruissen Fred
Serial analysis of gene expression in human keratinocytes and epidermis.
Methods in molecular biology (Clifton, N.J.) 2005;289():383-98.
-
2004: Zweers Manon C; Hakim Alan J; Grahame Rodney; Schalkwijk Joost
Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects.
Arthritis and rheumatism 2004;50(9):2742-9.
-
2004: Peeters A C T M; Kucharekova M; Timmermans J; van den Berkmortel F W P J; Boers G H J; Nováková I R O; Egging D; den Heijer M; Schalkwijk J
A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X.
The Netherlands journal of medicine 2004;62(5):160-2.
-
2004: Zeeuwen Patrick L J M; van Vlijmen-Willems Ivonne M J J; Olthuis Diana; Johansen Harald T; Hitomi Kiyotaka; Hara-Nishimura Ikuko; Powers James C; James Karen E; op den Camp Huub J; Lemmens Rob; Schalkwijk Joost
Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice.
Human molecular genetics 2004;13(10):1069-79.
-
2004: Zweers Manon C; van Vlijmen-Willems Ivonne M; van Kuppevelt Toin H; Mecham Robert P; Steijlen Peter M; Bristow Jim; Schalkwijk Joost
Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology.
The Journal of investigative dermatology 2004;122(4):885-91.
-
2004: Smetsers Toon F C M; van de Westerlo Els M A; ten Dam Gerdy B; Overes Ingrid M; Schalkwijk Joost; van Muijen Goos N P; van Kuppevelt Toin H
Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis.
The Journal of investigative dermatology 2004;122(3):707-16.
-
2004: Niessen Frank B; Schalkwijk Joost; Vos Hans; Timens Wim
Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells.
The Journal of pathology 2004;202(1):121-9.
-
2004: van Rossum Michelle M; Franssen Mainon E J; Cloin Wendy A H; van de Bosch Gerard J M; Boezeman Jan B M; Schalkwijk Joost; van de Kerkhof Peter C M; van Erp Piet E J
Functional characterization of beta1-integrin-positive epidermal cell populations.
Acta dermato-venereologica 2004;84(4):265-70.
-
2003: Jansen Bastiaan J H; van Ruissen Fred; Cerneus Stefanie; Cloin Wendy; Bergers Mieke; van Erp Piet E J; Schalkwijk Joost
Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes.
The Journal of investigative dermatology 2003;121(6):1433-9.
-
2003: Zweers Manon C; Bristow Jim; Steijlen Peter M; Dean Willow B; Hamel Ben C; Otero Marisol; Kucharekova Martina; Boezeman Jan B; Schalkwijk Joost
Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome.
American journal of human genetics 2003;73(1):214-7.
-
2003: Zeeuwen Patrick L J M; Dale Beverly A; de Jongh Gys J; van Vlijmen-Willems Ivonne M J J; Fleckman Philip; Kimball Janet R; Stephens Karen; Schalkwijk Joost
The human cystatin M/E gene (CST6): exclusion candidate gene for harlequin ichthyosis.
The Journal of investigative dermatology 2003;121(1):65-8.
-
2003: Kucharekova Martin; Vissers Wynand H P M; Schalkwijk Joost J; van de Kerkhof Peter C M; van der Valk Peter G M
Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation.
European journal of dermatology : EJD 2003;13(3):254-7.
-
2003: Kucharekova M; Hornix M; Ashikaga T; T'kint S; de Jongh G J; Schalkwijk J; van de Kerkhof P C M; van der Valk P G M
The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.
Archives of dermatological research 2003;295(1):29-32.
-
2003: Pol Arno; Pfundt Rolph; Zeeuwen Patrick; Molhuizen Henri; Schalkwijk Joost
Transcriptional regulation of the elafin gene in human keratinocytes.
The Journal of investigative dermatology 2003;120(2):301-7.
-
2003: Jansen Bastiaan J H; Schalkwijk Joost
Transcriptomics and proteomics of human skin.
Briefings in functional genomics & proteomics 2003;1(4):326-41.
-
2003: Pol Arno; Bergers Mieke; Schalkwijk Joost
Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay.
In vitro cellular & developmental biology. Animal 2003;39(1-2):36-42.
-
2002: Zeeuwen Patrick L J M; van Vlijmen-Willems Ivonne M J J; Hendriks Wiljan; Merkx Gerard F M; Schalkwijk Joost
A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification.
Human molecular genetics 2002;11(23):2867-75.
-
2002: van Rossum M M; Schalkwijk J; van de Kerkhof P C M; van Erp P E J
Immunofluorescent surface labelling, flow sorting and culturing of putative epidermal stem cells derived from small skin punch biopsies.
Journal of immunological methods 2002;267(2):109-17.
-
2002: Pol Arno; van Ruissen Fred; Schalkwijk Joost
Development of a keratinocyte-based screening model for antipsoriatic drugs using green fluorescent protein under the control of an endogenous promoter.
Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening 2002;7(4):325-32.
-
2002: Pol Arno; Bergers Mieke; van Ruissen Fred; Pfundt Rolph; Schalkwijk Joost
A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes.
Skin pharmacology and applied skin physiology 2002;15(4):252-61.
-
2002: Zeeuwen P L J M; van Vlijmen-Willems I M J J; Egami H; Schalkwijk J
Cystatin M / E expression in inflammatory and neoplastic skin disorders.
The British journal of dermatology 2002;147(1):87-94.
-
2002: Kucharekova M; Schalkwijk J; Van De Kerkhof P C M; Van De Valk P G M
Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction.
Contact dermatitis 2002;46(6):331-8.
-
2002: van Ruissen Fred; Jansen Bastiaan J H; de Jongh Gys J; Zeeuwen Patrick L J M; Schalkwijk Joost
A partial transcriptome of human epidermis.
Genomics 2002;79(5):671-8.
-
2002: van Ruissen Fred; Jansen Bastiaan J H; de Jongh Gys J; van Vlijmen-Willems Ivonne M J J; Schalkwijk Joost
Differential gene expression in premalignant human epidermis revealed by cluster analysis of serial analysis of gene expression (SAGE) libraries.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(2):246-8.
-
2001: Schalkwijk J; Zweers M C; Steijlen P M; Dean W B; Taylor G; van Vlijmen I M; van Haren B; Miller W L; Bristow J
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
The New England journal of medicine 2001;345(16):1167-75.
-
2001: Vandermeeren M; Daneels G; Bergers M; van Vlijmen-Willems I; Pol A; Geysen J; Schalkwijk J
Development and application of monoclonal antibodies against SKALP/elafin and other trappin family members.
Archives of dermatological research 2001;293(7):343-9.
-
2001: Niessen F B; Andriessen M P; Schalkwijk J; Visser L; Timens W
Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars.
The Journal of pathology 2001;194(2):207-16.
-
2001: Zeeuwen P L; Van Vlijmen-Willems I M; Jansen B J; Sotiropoulou G; Curfs J H; Meis J F; Janssen J J; Van Ruissen F; Schalkwijk J
Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase.
The Journal of investigative dermatology 2001;116(5):693-701.
-
2001: Pfundt R; van Vlijmen-Willems I; Bergers M; Wingens M; Cloin W; Schalkwijk J
In situ demonstration of phosphorylated c-jun and p38 MAP kinase in epidermal keratinocytes following ultraviolet B irradiation of human skin.
The Journal of pathology 2001;193(2):248-55.
-
2001: Jansen B J; van Ruissen F; de Jongh G; Zeeuwen P L; Schalkwijk J
Serial analysis of gene expression in differentiated cultures of human epidermal keratinocytes.
The Journal of investigative dermatology 2001;116(1):12-22.
-
2000: Latijnhouwers M A; de Jongh G J; Bergers M; de Rooij M J; Schalkwijk J
Expression of tenascin-C splice variants by human skin cells.
Archives of dermatological research 2000;292(9):446-54.
-
2000: van Wetering S; van der Linden A C; van Sterkenburg M A; Rabe K F; Schalkwijk J; Hiemstra P S
Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2000;48(5):359-66.
-
2000: Pfundt R; Wingens M; Bergers M; Zweers M; Frenken M; Schalkwijk J
TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway.
Archives of dermatological research 2000;292(4):180-7.
-
2000: van Wetering S; van der Linden A C; van Sterkenburg M A; de Boer W I; Kuijpers A L; Schalkwijk J; Hiemstra P S
Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.
American journal of physiology. Lung cellular and molecular physiology 2000;278(1):L51-8.
-
1999: Wingens M; Pfundt R; van Vlijmen-Willems I M; van Hooijdonk C A; van Erp P E; Schalkwijk J
Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
Laboratory investigation; a journal of technical methods and pathology 1999;79(11):1415-24.
-
1999: Niessen F B; Spauwen P H; Schalkwijk J; Kon M
On the nature of hypertrophic scars and keloids: a review.
Plastic and reconstructive surgery 1999;104(5):1435-58.
-
1999: Schalkwijk J; Wiedow O; Hirose S
The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.
The Biochemical journal 1999;340 ( Pt 3)():569-77.
-
1998: Wingens M; van Bergen B H; Hiemstra P S; Meis J F; van Vlijmen-Willems I M; Zeeuwen P L; Mulder J; Kramps H A; van Ruissen F; Schalkwijk J
Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes.
The Journal of investigative dermatology 1998;111(6):996-1002.
-
1998: Andriessen M P; Niessen F B; Van de Kerkhof P C; Schalkwijk J
Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study.
The Journal of pathology 1998;186(2):192-200.
-
1998: Kuijpers A L; Van Pelt J P; Bergers M; Boegheim P J; Den Bakker J E; Siegenthaler G; Van de Kerkhof P C; Schalkwijk J
The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
The British journal of dermatology 1998;139(3):380-9.
-
1998: Latijnhouwers M A; Bergers M; Veenhuis R T; Beekman B; Ankersmit-Ter Horst M F; Schalkwijk J
Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity.
Archives of dermatological research 1998;290(9):490-6.
-
1998: Latijnhouwers M A; Bergers M; Kuijpers A L; van der Vleuten C J; Dijkman H; van de Kerkhof P C; Schalkwijk J
Tenascin-C is not a useful marker for disease activity in psoriasis.
Acta dermato-venereologica 1998;78(5):331-4.
-
1998: Latijnhouwers M A; Pfundt R; de Jongh G J; Schalkwijk J
Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway.
Matrix biology : journal of the International Society for Matrix Biology 1998;17(4):305-16.
-
1998: Kuijpers A L; Pfundt R; Zeeuwen P L; Molhuizen H O; Mariman E C; van de Kerkhof P C; Schalkwijk J
SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis.
Clinical genetics 1998;54(1):96-101.
-
1998: van Ruissen F; Le M; Carroll J M; van der Valk P G; Schalkwijk J
Differential effects of detergents on keratinocyte gene expression.
The Journal of investigative dermatology 1998;110(4):358-63.
-
1998: Wingens M; van Hooijdonk C A; de Jongh G J; Schalkwijk J; van Erp P E
Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.
Archives of dermatological research 1998;290(3):119-25.
-
1998: Le T K; Schalkwijk J; van de Kerkhof P C; van Haelst U; van der Valk P G
A histological and immunohistochemical study on chronic irritant contact dermatitis.
American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 1998;9(1):23-8.
-
1997: Andriessen M P; van den Born J; Latijnhouwers M A; Bergers M; van de Kerkhof P C; Schalkwijk J
Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin.
The Journal of pathology 1997;183(3):264-71.
-
1997: Zeeuwen P L; Hendriks W; de Jong W W; Schalkwijk J
Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature.
The Journal of biological chemistry 1997;272(33):20471-8.
-
1997: Kuijpers A L; Schalkwijk J; Rulo H F; Peperkamp J J; van de Kerkhof P C; de Jong E M
Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis.
The British journal of dermatology 1997;137(1):123-9.
-
1997: Le T K; De Mon P; Schalkwijk J; van der Valk P G
Effect of a topical corticosteroid, a retinoid and a vitamin D3 derivative on sodium dodecyl sulphate induced skin irritation.
Contact dermatitis 1997;37(1):19-26.
-
1997: Swart G W; van Groningen J J; van Ruissen F; Bergers M; Schalkwijk J
Transcription factor C/EBPalpha: novel sites of expression and cloning of the human gene.
Biological chemistry 1997;378(5):373-9.
-
1997: Latijnhouwers M; Bergers M; Ponec M; Dijkman H; Andriessen M; Schalkwijk J
Human epidermal keratinocytes are a source of tenascin-C during wound healing.
The Journal of investigative dermatology 1997;108(5):776-83.
-
1997: Kuijpers A L; Bergers M; Siegenthaler G; Zeeuwen P L; van de Kerkhof P C; Schalkwijk J
Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
Acta dermato-venereologica 1997;77(1):14-9.
-
1996: Le M; Schalkwijk J; Siegenthaler G; van de Kerkhof P C; Veerkamp J H; van der Valk P G
Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.
Archives of dermatological research 1996;288(11):684-90.
-
1996: Kuijpers A L; Zeeuwen P L; de Jongh G J; van de Kerkhof P C; Alkemade H A; Schalkwijk J
Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?
Archives of dermatological research 1996;288(11):641-7.
-
1996: Pfundt R; van Ruissen F; van Vlijmen-Willems I M; Alkemade H A; Zeeuwen P L; Jap P H; Dijkman H; Fransen J; Croes H; van Erp P E; Schalkwijk J
Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.
The Journal of clinical investigation 1996;98(6):1389-99.
-
1996: van Ruissen F; de Jongh G J; van Erp P E; Boezeman J B; Schalkwijk J
Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals.
Journal of cellular physiology 1996;168(3):684-94.
-
1996: Van Ruissen F; de Jongh G J; Zeeuwen P L; Van Erp P E; Madsen P; Schalkwijk J
Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
Journal of cellular physiology 1996;168(2):442-52.
-
1996: van Bergen B H; Andriessen M P; Spruijt K I; van de Kerkhof P C; Schalkwijk J
Expression of SKALP/elafin during wound healing in human skin.
Archives of dermatological research 1996;288(8):458-62.
-
1996: Hendriks W; Brugman C; Richter K H; van Hooijdonk C; Schepens J; Schalkwijk J; Wieringa B
Protein-tyrosine phosphatases expressed in mouse epidermal keratinocytes.
The Journal of investigative dermatology 1996;106(5):972-6.
-
1996: Latijnhouwers M A; Bergers M; Van Bergen B H; Spruijt K I; Andriessen M P; Schalkwijk J
Tenascin expression during wound healing in human skin.
The Journal of pathology 1996;178(1):30-5.
-
1996: Le M; Cals S; Schalkwijk J; van der Valk P
An immunohistochemical study on mild skin irritation induced by a single application of a low-molarity sodium dodecyl sulfate solution: keys to the prevention of irritant contact dermatitis.
Current problems in dermatology 1996;25():67-77.
-
1995: Andriessen M P; van Bergen B H; Spruijt K I; Go I H; Schalkwijk J; van de Kerkhof P C
Epidermal proliferation is not impaired in chronic venous ulcers.
Acta dermato-venereologica 1995;75(6):459-62.
-
1995: Le T K; van der Valk P G; Schalkwijk J; van de Kerkhof P C
Changes in epidermal proliferation and differentiation in allergic and irritant contact dermatitis reactions.
The British journal of dermatology 1995;133(2):236-40.
-
1995: Van Ruissen F; Van de Kerkhof P C; Schalkwijk J
Signal transduction pathways in epidermal proliferation and cutaneous inflammation.
Clinics in dermatology 1995;13(2):161-90.
-
1995: Kuijpers A L; Alkemade H A; Schalkwijk J; van de Kerkhof P C
Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis.
Acta dermato-venereologica 1995;75(2):110-3.
-
1995: Alkemade H A; de Jongh G J; Arnold W P; van de Kerkhof P C; Schalkwijk J
Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.
The Journal of investigative dermatology 1995;104(2):189-93.
-
1995: Molhuizen H O; Schalkwijk J
Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI.
Biological chemistry Hoppe-Seyler 1995;376(1):1-7.
-
1994: Alkemade H A; van Vlijmen-Willems I M; van Haelst U J; van de Kerkhof P C; Schalkwijk J
Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
The Journal of pathology 1994;174(2):121-9.
-
1994: Alkemade J A; Molhuizen H O; Ponec M; Kempenaar J A; Zeeuwen P L; de Jongh G J; van Vlijmen-Willems I M; van Erp P E; van de Kerkhof P C; Schalkwijk J
SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.
Journal of cell science 1994;107 ( Pt 8)():2335-42.
-
1994: van Ruissen F; van Erp P E; de Jongh G J; Boezeman J B; van de Kerkhof P C; Schalkwijk J
Cell kinetic characterization of growth arrest in cultured human keratinocytes.
Journal of cell science 1994;107 ( Pt 8)():2219-28.
-
1994: Van Duijnhoven-Avontuur W M; Alkemade J A; Schalkwijk J; Mier P D; Van der Valk P G
The inflammatory and proliferative response of normal skin in a model for acute chemical injury: ornithine decarboxylase induction as a common feature in various models for acute skin injury.
The British journal of dermatology 1994;130(6):725-30.
-
1994: Steijlen P M; Maessen E; Kresse H; Van Vlijmen I M; Verstraeten A A; Traupe H; Schalkwijk J
Expression of tenascin, biglycan and decorin in disorders of keratinization.
The British journal of dermatology 1994;130(5):564-8.
-
1994: Van Baar H M; Van Vlijmen I M; Ramaekers F C; Van Muijen G N; Troyanovsky S M; Perret C M; Van de Kerkhof P C; Schalkwijk J
Cytokeratin expression in alopecia areata hair follicles.
Acta dermato-venereologica 1994;74(1):28-32.
-
1994: Molhuizen H O; Zeeuwen P L; Olde Weghuis D; Geurts van Kessel A; Schalkwijk J
Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13.
Cytogenetics and cell genetics 1994;66(2):129-31.
-
1994: van Erp P E; de Jongh G J; Boezeman J B; Schalkwijk J
The growth and differentiation of human keratinocytes in vitro: a combined immunohistochemical and flow cytometric study.
Archives of dermatological research 1994;286(2):115-22.
-
1993: Alkemade H A; Molhuizen H O; van Vlijmen-Willems I M; van Haelst U J; Schalkwijk J
Differential expression of SKALP/Elafin in human epidermal tumors.
The American journal of pathology 1993;143(6):1679-87.
-
1993: van Hooijdonk C A; van Erp P E; Freund R L; de Jongh G J; Schalkwijk J; van de Kerkhof P C; Mier P D
Cell kinetic characterization of the epidermal growth factor dependent BALB/MK line using flow cytometric analysis of DNA content and iododeoxyuridine incorporation.
Cell proliferation 1993;26(6):567-76.
-
1993: Molhuizen H O; Alkemade H A; Zeeuwen P L; de Jongh G J; Wieringa B; Schalkwijk J
SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.
The Journal of biological chemistry 1993;268(16):12028-32.
-
1993: Schalkwijk J; van Vlijmen I M; Alkemade J A; de Jongh G J
Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.
The Journal of investigative dermatology 1993;100(4):390-3.
-
1993: Rulo H F; van Vlijmen-Willems I M; Schalkwijk J; Verstraeten A A; van de Kerkhof P C
Normal human skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal proliferation (Ki-67 binding).
Journal of dermatological science 1993;5(1):54-7.
-
1992: Verstraeten A A; Mackie E J; Hageman P C; Hilgers J; Schol D J; De Jongh G J; Schalkwijk J
Tenascin expression in basal cell carcinoma.
The British journal of dermatology 1992;127(6):571-4.
-
1992: Alkemade H; van de Kerkhof P; Schalkwijk J
Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
The Journal of investigative dermatology 1992;99(1):3-7.
-
1992: van Duijnhoven J L; Schalkwijk J; Kranenborg M H; van Vlijmen-Willems I M; Groeneveld A; van Erp P E; Timmer E D; de Jongh G J; van de Ven W J
MON-150, a versatile monoclonal antibody against involucrin: characterization and applications.
Archives of dermatological research 1992;284(3):167-72.
-
1992: van Baar H M; Perret C M; van Vlijmen I M; van de Kerkhof P C; Happle R; Schalkwijk J
Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
Acta dermato-venereologica 1992;72(3):161-4.
-
1991: Schalkwijk J; Steijlen P M; van Vlijmen-Willems I M; Oosterling B; Mackie E J; Verstraeten A A
Tenascin expression in human dermis is related to epidermal proliferation.
The American journal of pathology 1991;139(5):1143-50.
-
1991: Schalkwijk J; de Roo C; de Jongh G J
Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.
Biochimica et biophysica acta 1991;1096(2):148-54.
-
1991: Van de Kerkhof P C; Kuppens L H; Van Vlijmen Y; Schalkwijk J
Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion.
The British journal of dermatology 1991;124(1):10-2.
-
1991: Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie E J
Tenascin expression in hyperproliferative skin diseases.
The British journal of dermatology 1991;124(1):13-20.
-
1991: van Erp P E; Jansen M J; de Jongh G J; Boezeman J B; Schalkwijk J
Ratiometric measurement of intracellular pH in cultured human keratinocytes using carboxy-SNARF-1 and flow cytometry.
Cytometry 1991;12(2):127-32.
-
1991: van Baar H M; Perret C M; van Vlijmen-Willems I M; Cleutjens J P; Mackie E J; Happle R; Schalkwijk J
Expression of tenascin in perifollicular connective tissue: comparison of normal scalp and alopecia areata.
Archives of dermatological research 1991;283(2):86-90.
-
1990: Schalkwijk J; Joosten L A; van den Berg W B; van de Putte L B
Antigen induced arthritis in beige (Chediak-Higashi) mice.
Annals of the rheumatic diseases 1990;49(8):607-10.
-
1990: Schalkwijk J; Chang A; Janssen P; De Jongh G J; Mier P D
Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis.
The British journal of dermatology 1990;122(5):631-41.
-
1990: Van Baar H M; Schalkwijk J; Perret C M
Cryosectioning of hair follicles. An improved method using liquid nitrogen conduction freezing.
Acta dermato-venereologica 1990;70(4):335-8.
-
1990: Chang A; Schalkwijk J; Happle R; van de Kerkhof P C
Elastase-inhibiting activity in scaling skin disorders.
Acta dermato-venereologica 1990;70(2):147-51.
-
1989: van Erp P E; Rijzewijk J J; Boezeman J B; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof P C; Ramaekers F C; Bauer F W
Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
The American journal of pathology 1989;135(5):865-70.
-
1989: Schalkwijk J; Joosten L A; van den Berg W B; van de Putte L B
Chondrocyte nonresponsiveness to insulin-like growth factor 1 in experimental arthritis.
Arthritis and rheumatism 1989;32(7):894-900.
-
1989: van Beuningen H M; van den Berg W B; Schalkwijk J; Arntz O J; van de Putte L B
Age- and sex-related differences in antigen-induced arthritis in C57Bl/10 mice.
Arthritis and rheumatism 1989;32(6):789-94.
-
1989: Schalkwijk J; Joosten L A; van den Berg W B; van Wyk J J; van de Putte L B
Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid.
Arthritis and rheumatism 1989;32(1):66-71.
-
1989: Joosten L A; Schalkwijk J; van den Berg W B; van de Putte L B
Chondrocyte unresponsiveness to insulin-like growth factor-1. A novel pathogenetic mechanisms for cartilage destruction in experimental arthritis.
Agents and actions 1989;26(1-2):193-5.
-
1988: Schalkwijk J; Joosten L A; van den Berg W B; van de Putte L B
Experimental arthritis in C57black/6 normal and beige (Chediak-Higashi) mice: in vivo and in vitro observations on cartilage degradation.
Annals of the rheumatic diseases 1988;47(11):940-6.
-
1988: van Beuningen H M; van den Berg W B; Schalkwijk J; Arntz O J; van de Putte L B
Age-related changes in joint damage caused by antigen-induced arthritis in mice.
Agents and actions 1988;23(1-2):74-6.
-
1987: van Lent P L; van den Berg W B; Schalkwijk J; van de Putte L B; van den Bersselaar L
Allergic arthritis induced by cationic antigens: relationship of chronicity with antigen retention and T-cell reactivity.
Immunology 1987;62(2):265-72.
-
1987: van Lent P L; van den Berg W B; Schalkwijk J; van de Putte L B; van den Bersselaar L
The impact of protein size and charge on its retention in articular cartilage.
The Journal of rheumatology 1987;14(4):798-805.
-
1987: van Baar H M; van de Kerkhof P C; Schalkwijk J; Mier P D
Cutaneous superoxide dismutase activity in psoriasis.
The British journal of dermatology 1987;116(3):462-3.
-
1985: Schalkwijk J; van den Berg W B; van de Putte L B; Joosten L A; van den Bersselaar L
Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice.
The Journal of clinical investigation 1985;76(1):198-205.
Sign-in to see more
